Diagnostic value of follistatin gene mutations in women with polycystic ovary syndrome

被引:0
|
作者
Zia, Sadia [1 ]
Mushtaq, Maham [1 ]
Saleem, Mushtaq Ahmed [1 ]
机构
[1] Univ Cent Punjab, Lahore, Pakistan
来源
RAWAL MEDICAL JOURNAL | 2019年 / 44卷 / 04期
关键词
Mutation; Follistatin gene; polycystic ovary syndrome; hyperandrogenism; ANTI-MULLERIAN HORMONE; ANDROGEN RECEPTOR; HYPERANDROGENISM; INFERTILITY; VARIANTS; FEATURES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is consider as the most common endocrine disorder in women of reproductive age. Strong evidence for a link between the follistatin gene and PCOS has been found in different studies.Follistatin binds to activin and affects its functions, secretion, and stimulation of FSH synthesis (follicle-stimulating hormone). It plays an important role in the functional impairment of the FSH-granulosa cell axis in PCOS. Gene implicated in ovarian follicular development may have a role in the etiology of PCOS, as demonstrated by the identification of the follistatin gene as a potential disease locus. It seems unlikely that PCOS can be explained based on single-gene disorder. One gene may have a predominant effect. Follistatin has been reported as a candidate gene for PCOS for linkage and associated studies. The objective of this review is to define the linkage between PCOS and the follistatin gene and the diagnostic value of PCOS.
引用
收藏
页码:875 / 879
页数:5
相关论文
共 50 条
  • [21] Association Study of Gene LPP in Women with Polycystic Ovary Syndrome
    Zhang, Bo
    Zhao, Han
    Li, Tao
    Gao, Xuan
    Gao, Qin
    Tang, Rong
    Zhang, Jiangtao
    Chen, Zi-Jiang
    PLOS ONE, 2012, 7 (10):
  • [22] Plasminogen Activator Inhibitor 1 and Methylenetetrahydrofolate Reductase Gene mutations in Iranian Women with Polycystic Ovary Syndrome
    Idali, Farah
    Zareii, Said
    Mohammad-Zadeh, Afsane
    Reihany-Sabet, Fakhreddin
    Akbarzadeh-Pasha, Zoreh
    Khorram-Khorshid, Hamid-Reza
    Zarnani, Amir-Hassan
    Jeddi-Tehrani, Mahmood
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2012, 68 (05) : 400 - 407
  • [24] The Diagnostic Experiences of Women With Polycystic Ovary Syndrome (PCOS) in Ontario, Canada
    Soucie, Kendall
    Samardzic, Tanja
    Schramer, Kristin
    Ly, Cindy
    Katzman, Rachel
    QUALITATIVE HEALTH RESEARCH, 2021, 31 (03) : 523 - 534
  • [25] Identification of potential diagnostic genes for atherosclerosis in women with polycystic ovary syndrome
    Luo, Yujia
    Zhou, Yuanyuan
    Jiang, Hanyue
    Zhu, Qiongjun
    Lv, Qingbo
    Zhang, Xuandong
    Gu, Rui
    Yan, Bingqian
    Wei, Li
    Zhu, Yuhang
    Jiang, Zhou
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] Diagnostic criteria in polycystic ovary syndrome
    Legro, RS
    SEMINARS IN REPRODUCTIVE MEDICINE, 2003, 21 (03) : 267 - 275
  • [27] Diagnostic features of polycystic ovary syndrome
    Barday-Karbanee, N.
    Siebert, T. I.
    Botha, M. H.
    Kruger, T. F.
    SAJOG-SOUTH AFRICAN JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 12 (01): : 30 - 35
  • [28] Polycystic ovary syndrome - A diagnostic challenge
    Lewis, V
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2001, 28 (01) : 1 - +
  • [29] Follistatin and activins in polycystic ovary syndrome: Relationship to metabolic and hormonal markers
    Teede, Helena
    Ng, Sze
    Hedger, Mark
    Moran, Lisa
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (10): : 1394 - 1400
  • [30] Vascular risk in young women with polycystic ovary and polycystic ovary syndrome
    Battaglia, Cesare
    Mancini, Fulvia
    Cianciosi, Arianna
    Busacchi, Paolo
    Facchinetti, Fabio
    Marchesini, Giulio Reggiani
    Marzocchi, Rebecca
    de Aloysio, Domenico
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (02): : 385 - 395